Delivery Order SPE2DB20D1100-SPE2DB25FA0F1

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,612.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of FOSAMAX 70 MG TABLET, a prescription medication, with a completion date of May 8, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.98 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG TABLET UU 4S, a medical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,283.85 firm fixed-price delivery order is for the supply of FOSAMAX 70 MG TABLET medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) is a Delivery Order valued at $11,834.34 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FOSAMAX 70 MG TABLET and has an ultimate completion date of May 17, 2023. This IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,313.70, is a Firm Fixed Price Delivery Order to supply the government with FOSAMAX 70 MG TABLET medication. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,898.78, is for the delivery of FOSAMAX 70 MG TABLET pharmaceutical products. It has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,282.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564491503 FOSAMAX 70 MG tablets, a medication used for the treatment of osteoporosis. The award has an ultimate completion date of May 6, 2024 and is a Firm Fixed Price Delivery Order contract. This contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The award, valued at $4,008.21, is for the delivery of Fosamax 70 MG Tablet pharmaceutical products to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,896.12 firm fixed price delivery order is for the supply of FOSAMAX 70 MG TABLET medical products. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,316.92 firm fixed-price delivery order is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a completion date of January 7, 2025. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA0F1
    Delivery Order

This federal contract award, valued at $2,401.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of FOSAMAX 70 MG TABLET UU 4S, a prescription medication.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 4/21/25, 3:35 AM